Core One Labs' Akome Move Psychedelic Drug Formulations to Next Stage of Development: Initiating Phase 2 Analysis of Therapeutic ...
VANCOUVER, BC / ACCESSWIRE / September 16, 2022 / Core One Labs Inc. COOL, CLABF, LD6A (the "Company" or "Core One") is pleased to announce that following the receipt of very positive results during phase one ("Phase 1") pre- …